About Yew Bio-Pharm Group (OTCMKTS:YEWB)
Yew Bio-Pharm Group, Inc. is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The Company operates through five segments: traditional Chinese medicine (TCM) raw materials, which is engaged in the production and sale of raw materials used for medicinal application in the pharmaceutical industry; yew trees, which is engaged in the cultivation and sale of yew seedlings, yew trees and potted yew trees; handicrafts, which is engaged in the manufacture and sale of furniture and handicrafts made of yew timber; wood ear mushroom, which includes the sale of wood ear mushroom, and others, which includes the sale of yew candles and pine needle extracts. It is engaged in processing and selling yew raw materials used in the manufacture of TCM; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber, and selling agricultural products.
Industry, Sector and Symbol
Industry Farm Products
Trailing P/E Ratio1.61111111111111
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$51.35 million
Price / Sales0.29
Cash Flow$0.21 per share
Price / Cash1.38
Book Value$0.74 per share
Price / Book0.39
Net Income$2 million
Return on Equity21.43%
Return on Assets18.06%
Yew Bio-Pharm Group (OTCMKTS:YEWB) Frequently Asked Questions
What is Yew Bio-Pharm Group's stock symbol?
Yew Bio-Pharm Group trades on the OTCMKTS under the ticker symbol "YEWB."
How were Yew Bio-Pharm Group's earnings last quarter?
Yew Bio-Pharm Group Inc (OTCMKTS:YEWB) posted its quarterly earnings data on Monday, November, 13th. The company reported $0.01 EPS for the quarter. The firm earned $11.57 million during the quarter. Yew Bio-Pharm Group had a return on equity of 21.43% and a net margin of 20.42%. View Yew Bio-Pharm Group's Earnings History.
When will Yew Bio-Pharm Group make its next earnings announcement?
Who are some of Yew Bio-Pharm Group's key competitors?
Some companies that are related to Yew Bio-Pharm Group include RegeneRx Biopharmaceuticals (RGRX), Wentworth Resource (WENTF), Innovus Pharmaceuticals (INNV), TCP International (TCPIF), Sevion Therapeutics (SVON), HealthWarehouse.com (HEWA), Pacific Drilling (PACDQ), Windtree Therapeutics (WINT), Acura Pharmaceuticals (ACUR), Sierra Monitor (SRMC), Black Ridge Oil & Gas (ANFC), Destiny Media Technologies (DSNY), Deep Down (DPDW), OMNI-LITE INDS CAN (OLNCF), Critical Outcome T (COTQF), Atna Resources (ATNAQ), Noble Roman's (NROM) and Premier (PRHL).
Who are Yew Bio-Pharm Group's key executives?
Yew Bio-Pharm Group's management team includes the folowing people:
- Zhiguo Wang, Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Secretary (Age 50)
- Guifang Qi, Treasurer, Director (Age 51)
- Xingming Han, General Manager of HDS and Director (Age 48)
How do I buy Yew Bio-Pharm Group stock?
Shares of Yew Bio-Pharm Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Yew Bio-Pharm Group's stock price today?
One share of Yew Bio-Pharm Group stock can currently be purchased for approximately $0.29.
How big of a company is Yew Bio-Pharm Group?
Yew Bio-Pharm Group has a market capitalization of $15.04 million and generates $51.35 million in revenue each year. The company earns $2 million in net income (profit) each year or $0.18 on an earnings per share basis. Yew Bio-Pharm Group employs 86 workers across the globe.
How can I contact Yew Bio-Pharm Group?
Yew Bio-Pharm Group's mailing address is 9460 Telstar Ave Ste 6, EL MONTE, CA 91731-2904, United States. The company can be reached via phone at +1-626-4019588 or via email at [email protected]
MarketBeat Community Rating for Yew Bio-Pharm Group (YEWB)MarketBeat's community ratings are surveys of what our community members think about Yew Bio-Pharm Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Yew Bio-Pharm Group (OTCMKTS:YEWB) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Yew Bio-Pharm Group (OTCMKTS:YEWB) Earnings History and Estimates Chart
Yew Bio-Pharm Group (OTCMKTS YEWB) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/30/2018|| || || || || || || || |
|11/13/2017||Q3 2017||$0.01||$11.57 million||View||N/A|
Yew Bio-Pharm Group (OTCMKTS:YEWB) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Yew Bio-Pharm Group (OTCMKTS:YEWB)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Yew Bio-Pharm Group (OTCMKTS YEWB)
No insider trades for this company have been tracked by MarketBeat.com
Yew Bio-Pharm Group (OTCMKTS YEWB) News Headlines
Yew Bio-Pharm Group (OTCMKTS:YEWB) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Yew Bio-Pharm Group (OTCMKTS YEWB) Stock Chart for Tuesday, January, 23, 2018